Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 3, 2023

Role of the Comprehensive Care Team

  • Additional MS resource sites
    /
 source:  The Consortium of Multiple Sclerosis Centers The world of multiple sclerosis has changed during the past two decades. There…
Additional MS resource sites

March 2, 2023

Register for Virtual MS WELLNESS event – taking place on March 18th

  • MS Diet & Nutrition
    /
  • MS Educational Programs
    /
  • MS PODCASTS
    /
  • Multiple Sclerosis
    /
March is MS Awareness Month. Let’s take this opportunity to raise awareness about living with MS! Through having a better…
MS Diet & Nutrition

March 2, 2023

Are you on a Biologic Medication? What you need to know about biosimilar treatment options.

  • Misc. MS Related
    /
  • MS Drug Therapies
    /
  • MS Specialty Pharmacy
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
—————– Vea esta página en español The Food and Drug Administration (FDA) has approved many biologics (also called biological products),…
Misc. MS Related

March 1, 2023

Astrocyte receptors may help to ease MS cognitive issues – presented at ACTRIMS 2023

  • Memory (Cognition)
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 by Lindsey Shapiro, PhD | February 28, 2023  MS mouse models genetically engineered to lack these receptors, called TNFR2, showed…
Memory (Cognition)

March 1, 2023

FDA Approves Tascenso ODT® (fingolimod), similar to Gilenya, for Relapsing MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
 February 21, 2023 The U.S. Food and Drug Administration recently approved Tascenso ODT® (fingolimod, Cycle Pharmaceuticals) as an orally disintegrating tablet…
MS Drug Therapies

February 28, 2023

Octave Presents Data from Nine Company and Partner Abstracts at ACTRIMS Forum 2023 on MSDA and more

  • Digital Therapeutics
    /
  • MRI
    /
  • MS Research Study and Reports
    /
 Real-world data sets show components of value-based care, use of Octave’s Multiple Sclerosis Disease Activity test and deep scan biomarker…
Digital Therapeutics

February 28, 2023

ACTRIMS 2023: Loss of myelin in spinal cord tied to MS disability

  • MS Research Study and Reports
    /
 More loss in cervical region also linked to worse motor function by Lindsey Shapiro, PhD | February 27, 2023 A…
MS Research Study and Reports

February 28, 2023

MS and Concussions

  • Additional MS resource sites
    /
  • MS Research Study and Reports
    /
  MS and Concussions The exact cause of MS isn’t known, although experts believe that a number of things play…
Additional MS resource sites

February 28, 2023

‘Usual Suspect’ Lesions Appear Not to Cause Most Severe Disability in Multiple Sclerosis Patients

  • MS Research Study and Reports
    /
Presented at 2023 ACTRIMS in San Diego, Ca  Summary: While brain lesions may be a key marker for Multiple Sclerosis, they…
MS Research Study and Reports

February 28, 2023

Study helps make clear distinctions between MS, MOGAD (Myelin oligodendrocyte glycoprotein antibody-associated disease)

  • MS Research Study and Reports
    /
  • Other Neuro Conditions
    /
 February 25, 2023 The study was presented at the 2023 #ACTRIMS forum A new study set out to assess potentially…
MS Research Study and Reports

Categories

Latest Blog Posts